TY - JOUR
T1 - Factors Influencing Health-Related Quality of Life of Patients with Spinocerebellar Ataxia
AU - the EUROSCA study group
AU - the ESMI study group
AU - Weber, Niklas
AU - Buchholz, Maresa
AU - Rädke, Anika
AU - Faber, Jennifer
AU - Schmitz-Hübsch, Tanja
AU - Jacobi, Heike
AU - Klockgether, Thomas
AU - Hoffmann, Wolfgang
AU - Michalowsky, Bernhard
AU - du Montcel, Sophie Tezenas
AU - Bauer, Peter
AU - Giunti, Paola
AU - Cook, Arron
AU - Labrum, Robyn
AU - Parkinson, Michael H.
AU - Durr, Alexandra
AU - Brice, Alexis
AU - Charles, Perrine
AU - Marelli, Cecilia
AU - Mariotti, Caterina
AU - Nanetti, Lorenzo
AU - Panzeri, Marta
AU - Rakowicz, Maria
AU - Sulek, Anna
AU - Sobanska, Anna
AU - Schöls, Ludger
AU - Hengel, Holger
AU - Baliko, Laszlo
AU - Melegh, Bela
AU - Filla, Alessandro
AU - Antenora, Antonella
AU - Infante, Jon
AU - Berciano, José
AU - van de Warrenburg, Bart P.
AU - Timmann, Dagmar
AU - Szymanski, Sandra
AU - Boesch, Sylvia
AU - Kang, Jun Suk
AU - Pandolfo, Massimo
AU - Schulz, Jörg B.
AU - Molho, Sonia
AU - Diallo, Alhassane
AU - Hübener-Schmid, Jeanette
AU - Santana, Magda
AU - Grobe-Einsler, Marcus
AU - Koyak, Berkan
AU - Raposo, Mafalda
AU - Lima, Manuela
AU - Gulin, Oz
AU - Joers, James
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/8
Y1 - 2024/8
N2 - Background: Little is known about the progression of health-related quality of life (HRQoL) and predicting factors in spinocerebellar ataxia (SCA). Such knowledge is crucial to identify modifiable factors promoting everyday life with SCA and attenuating HRQoL decline. Objectives: This study is to assess HRQoL progression and identify factors affecting SCA patients’ HRQoL. Methods: Longitudinal data (three-year follow-up) of 310 SCA patients of the European SCA3/Machado-Joseph-Disease Initiative (ESMI) (2016-2022) and 525 SCA patients (SCA1, SCA2, SCA3 or SCA6) of the EUROSCA natural history study cohort (2006–2015) were assessed. Both large cohort studies share standardized assessments of clinical measures, SARA, INAS, PHQ-9, and HRQoL (EQ-5D-3L). The association between HRQoL and clinical measures was assessed by Spearman Correlation (rs). Multivariable panel regression models were performed to evaluate the impact of patients’ socio-demographics, age of onset, SCA type and body mass index (BMI), and clinical measures on HRQoL progression. Results: HRQoL significantly decreased over one (− 0.014, p = 0.095), two (− 0.028, p = 0.003), and three years (− 0.032, p = 0.002). Ataxia severity and mental health strongly correlated with HRQoL (rsSARA = − 0.589; rsPHQ-9 = − 0.507). HRQoL more intensively declined in male (ß = − 0.024, p = 0.038) patients with an earlier age of onset (ß = 0.002, p = 0.058). Higher progression of ataxia severity (ß = − 0.010, p ≤ 0.001), mental health problems (ß = − 0.012, p < 0.001), and higher BMI (ß = − 0.003, p = 0.029) caused more severe decline of patients’ HRQoL over time. Discussion: In absence of curative treatments, stronger focus on mental health and weight influence could help clinical evaluation and accompany treatment improving SCA patients’ HRQoL, especially in male patients with early disease onset.
AB - Background: Little is known about the progression of health-related quality of life (HRQoL) and predicting factors in spinocerebellar ataxia (SCA). Such knowledge is crucial to identify modifiable factors promoting everyday life with SCA and attenuating HRQoL decline. Objectives: This study is to assess HRQoL progression and identify factors affecting SCA patients’ HRQoL. Methods: Longitudinal data (three-year follow-up) of 310 SCA patients of the European SCA3/Machado-Joseph-Disease Initiative (ESMI) (2016-2022) and 525 SCA patients (SCA1, SCA2, SCA3 or SCA6) of the EUROSCA natural history study cohort (2006–2015) were assessed. Both large cohort studies share standardized assessments of clinical measures, SARA, INAS, PHQ-9, and HRQoL (EQ-5D-3L). The association between HRQoL and clinical measures was assessed by Spearman Correlation (rs). Multivariable panel regression models were performed to evaluate the impact of patients’ socio-demographics, age of onset, SCA type and body mass index (BMI), and clinical measures on HRQoL progression. Results: HRQoL significantly decreased over one (− 0.014, p = 0.095), two (− 0.028, p = 0.003), and three years (− 0.032, p = 0.002). Ataxia severity and mental health strongly correlated with HRQoL (rsSARA = − 0.589; rsPHQ-9 = − 0.507). HRQoL more intensively declined in male (ß = − 0.024, p = 0.038) patients with an earlier age of onset (ß = 0.002, p = 0.058). Higher progression of ataxia severity (ß = − 0.010, p ≤ 0.001), mental health problems (ß = − 0.012, p < 0.001), and higher BMI (ß = − 0.003, p = 0.029) caused more severe decline of patients’ HRQoL over time. Discussion: In absence of curative treatments, stronger focus on mental health and weight influence could help clinical evaluation and accompany treatment improving SCA patients’ HRQoL, especially in male patients with early disease onset.
KW - EQ-5D
KW - Quality of life
KW - Spinocerebellar ataxia
KW - mental health
UR - http://www.scopus.com/inward/record.url?scp=85183166949&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85183166949&partnerID=8YFLogxK
U2 - 10.1007/s12311-024-01657-2
DO - 10.1007/s12311-024-01657-2
M3 - Article
C2 - 38279001
AN - SCOPUS:85183166949
SN - 1473-4222
VL - 23
SP - 1466
EP - 1477
JO - Cerebellum
JF - Cerebellum
IS - 4
ER -